Patent law issues related to new frontiers in pharmacogenomics: conditions of patentability in Europe and in the USA, best practice for agreements between university and industry
Supplementary protection certificates
The borderline between pharmaceutical products and medical devices
Revision of the EU legislation on medical devices and in vitro diagnostics
Personalised medicines
Data protection issues: bio-banking and data protection of biomarkers
Recent legislative developments
The implementation of the new legislation on pharmacovigilance (Regulation 1235/2010 and Directive 2010/84)
Adoption of Directive 2011/62 on the prevention of the entry into the legal supply chain of falsified medicinal products
Lawyers in private practice, in-house counsel and other practitioners of law dealing with pharma-ceuticals and medical devices, patents and consumer law.
